Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver (Q40120793)

17 September 2017

Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver (English)

1 reference

17 September 2017

8

Carlo Selmi

1 reference

17 September 2017

9

M Eric Gershwin

1 reference

17 September 2017

Makoto Fujimoto

1

1 reference

17 September 2017

Koichi Tsuneyama

2

1 reference

17 September 2017

Mosaburo Kainuma

3

1 reference

17 September 2017

Nobuyasu Sekiya

4

1 reference

17 September 2017

Hirozo Goto

5

1 reference

17 September 2017

Yasuo Takano

6

1 reference

17 September 2017

Katsutoshi Terasawa

7

1 reference

17 September 2017

Yutaka Shimada

10

1 reference

17 September 2017

1 March 2008

1 reference

Experimental Biology and Medicine

17 September 2017

1 reference

17 September 2017

233

1 reference

17 September 2017

3

1 reference

17 September 2017

328-337

1 reference

Traditional Chinese medicine and Kampo: a review from the distant past for the future.

17 September 2017

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

The role of vitamin E on the anti-atherosclerotic effect of fish oil in diet-induced hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Characterization of endothelium-dependent relaxation and modulation by treatment with pioglitazone in the hypercholesterolemic rabbit renal artery

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Brain adipocytokine action and metabolic regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Antioxidant activity and antimicrobial effect of berry phenolics--a Finnish perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Inhibitory activity of berberine on DNA strand cleavage induced by hydrogen peroxide and cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Serum leptin levels in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Human leptin: from an adipocyte hormone to an endocrine mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Liver injury in the setting of steatosis: crosstalk between adipokine and cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: possible role of the resistin and adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

The peptide specificities of the autoantibodies elicited by mouse hepatitis virus A59.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Chronic intermittent hypoxia predisposes to liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

Ectopic PDX-1 expression in liver ameliorates type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-207

21 January 2018

Identifiers

DOI

10.3181/0707-RM-207

1 reference

17 September 2017

1 reference